Lineage Cell Therapeutics, Inc. Increase (Decrease) in Due to Related Parties, Current
Lineage Cell Therapeutics, Inc. (LCTX) reported Increase (Decrease) in Due to Related Parties, Current of $760.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2017-11-09
- Lineage Cell Therapeutics, Inc. increase (decrease) in due to related parties, current for the quarter ending 2017-09-30 was $428.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in due to related parties, current for the quarter ending 2017-06-30 was $101.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in due to related parties, current for the quarter ending 2017-03-31 was $231.00K.
- Lineage Cell Therapeutics, Inc. increase (decrease) in due to related parties, current for the quarter ending 2016-09-30 was $0.00.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month |
|---|---|---|---|
| 2017-09-30 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $529.00K derived: sum of 2 quarters · filed 2017-11-09 | $760.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $332.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $231.00K 10-Q · filed 2017-05-10 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |